Right subclavian approach as a feasible alternative for transcatheter aortic valve implantation with the CoreValve ReValving System Testa L, Brambilla N, Laudisa M-L, De Carlo M, Lanotte S, Latini R, Pizzocri S, Casavecchia M, Agnifili M, Giannini C, Bortolotti U, Petronio A, Bedogni F October 26, 2012 | 10.4244/EIJV8I6A107
Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis Testa L, Agostoni P, Vermeersch P, Biondi-Zoccai G, van Gaal W, Bhindi R, Brilakis E, Latini R, Laudisa M-L, Pizzocri S, Lanotte S, Brambilla N, Banning A, Bedogni F September 30, 2010
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years (The Trials book is supported by Biotronik) December 13, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019